Analysed SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) News Sources
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
06-04-2026
yahoo.com
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
28-10-2025
yahoo.com
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
28-10-2025
yahoo.com
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
14-10-2025
yahoo.com
Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
14-10-2025
yahoo.com
Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
14-10-2025
yahoo.com
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
09-10-2025
yahoo.com
What is the current price of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)?
The current price of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) is $0.139.
SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) since the previous trading day is $-0.0106.
SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) since the previous trading day is -7.0856%.
What is the most recent average sentiment score for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)?
The most recent average sentiment score for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)?
The most recent sentiment for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) is .
SEC-8K** Filing Available For SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.